ロード中...
Cardioprotective Effect of Dexrazoxane in Patients with HER2-Positive Breast Cancer Who Receive Anthracycline Based Adjuvant Chemotherapy Followed by Trastuzumab
PURPOSE: We intended to determine whether dexrazoxane (DZR) is cardioprotective during administration of adjuvant anthracycline-based chemotherapy followed by a 1-year trastuzumab treatment. METHODS: The medical records of 228 patients who underwent surgical resection and received adjuvant chemother...
保存先:
| 出版年: | J Breast Cancer |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Korean Breast Cancer Society
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5378583/ https://ncbi.nlm.nih.gov/pubmed/28382098 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4048/jbc.2017.20.1.82 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|